Physiomics Plc (LON:PYC – Get Free Report) reached a new 52-week low on Tuesday . The company traded as low as GBX 0.40 ($0.01) and last traded at GBX 0.41 ($0.01), with a volume of 10026220 shares. The stock had previously closed at GBX 0.43 ($0.01).
Physiomics Stock Performance
The stock has a fifty day simple moving average of GBX 0.61 and a two-hundred day simple moving average of GBX 0.68. The stock has a market cap of £820,651.54, a PE ratio of -0.90 and a beta of 1.69.
Physiomics (LON:PYC – Get Free Report) last issued its quarterly earnings data on Thursday, March 6th. The company reported GBX (0.12) ($0.00) EPS for the quarter. Physiomics had a negative return on equity of 127.68% and a negative net margin of 106.80%. On average, equities analysts predict that Physiomics Plc will post -0.13 EPS for the current fiscal year.
About Physiomics
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.
Recommended Stories
- Five stocks we like better than Physiomics
- How to trade using analyst ratings
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- How to Start Investing in Real Estate
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.
